Nasty, Brutish, and Short: Embeddedness Failure in the Pharmaceutical Industry
Since the early 1990s, U.S. pharmaceutical firms have partially outsourced the coordination of the clinical trials they sponsor to specialized firms called contract research organizations. Although these exchanges appeared ripe for the development of close, “embedded” ties, they were in fact “n...
Main Authors: | Azoulay, Pierre, Repenning, Nelson, Zuckerman Sivan, Ezra W. |
---|---|
Other Authors: | Sloan School of Management |
Format: | Article |
Language: | en_US |
Published: |
Samuel Curtis Johnson Graduate School of Management, Cornell University
2011
|
Online Access: | http://hdl.handle.net/1721.1/64439 https://orcid.org/0000-0001-9832-131X https://orcid.org/0000-0001-6511-4824 https://orcid.org/0000-0002-6271-0708 |
Similar Items
-
Nasty beauty
by: Mohtarrudin, Norhafizah, et al.
Published: (2016) -
Death of the salesman but not the sales force: how interested promotion skews scientific valuation
by: Azoulay, Pierre, et al.
Published: (2020) -
Three essays on the development and diffusion of pharmaceutical innovations
by: Azoulay, Pierre
Published: (2005) -
Breaking up is hard to do: Irrational inconsistency in commitment to an industry peer network
by: Zuckerman Sivan, Ezra W, et al.
Published: (2017) -
Construction, Concentration, and (Dis)Continuities in Social Valuations
by: Zuckerman Sivan, Ezra W.
Published: (2013)